CBDG logo

THC Farmaceuticals, Inc. (CBDG) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CBDG representa a THC Farmaceuticals, Inc., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). Calificado con 42/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 15 mar 2026
Puntuación de IA de 42/100

THC Farmaceuticals, Inc. (CBDG) Resumen de Asistencia Médica y Tuberías

CEOEd Rosenthal
Sede CentralScottsdale, US
Año de la oferta pública inicial (OPI)2014
IndustriaBiotechnology

THC Farmaceuticals, Inc. (CBDG) operates a limited number of cash-dispensing ATMs in Utah, targeting small and medium-sized businesses in high-traffic areas. Formerly City Media, the company's current focus is on ATM services, distinguishing it from biotechnology peers despite its industry classification.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 15 mar 2026

Tesis de Inversión

THC Farmaceuticals, Inc. (CBDG) presents a speculative investment opportunity due to its limited operations and OTC market listing. The company's small ATM network in Utah generates revenue from transaction fees, but its financial viability is uncertain given the limited scale. Growth catalysts depend on expanding the ATM network and increasing transaction volume. Key risks include limited capital, competition from established ATM operators, and regulatory challenges associated with the OTC market. The company's negative P/E ratio of -55.69 and a beta of -9.64 reflect its volatile financial performance and market sensitivity.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Operates a small network of eight ATMs in Utah as of June 30, 2015.
  • Formerly known as City Media, Inc., changed its name to THC Farmaceuticals, Inc. in February 2015.
  • Subsidiary of Weed Growth Fund, Inc.
  • Targets small and medium-sized businesses in high-traffic areas.
  • P/E ratio of -55.69 indicates negative earnings.

Competidores y Pares

Fortalezas

  • Established ATM network in Utah.
  • Relationships with local businesses.
  • Convenient ATM locations.
  • Subsidiary of Weed Growth Fund, Inc.

Debilidades

  • Limited geographic scope.
  • Small ATM network.
  • Dependence on transaction fees.
  • Negative P/E ratio.

Catalizadores

  • Ongoing: Expansion of ATM network into new locations.
  • Ongoing: Strategic partnerships with local businesses.
  • Upcoming: Technological upgrades to existing ATMs.
  • Upcoming: Implementation of targeted marketing campaigns.
  • Upcoming: Diversification of services offered through ATMs.

Riesgos

  • Potential: Increased competition from larger ATM networks.
  • Potential: Shift towards digital payment solutions.
  • Potential: Regulatory changes affecting ATM operations.
  • Potential: Economic downturn impacting transaction volume.
  • Ongoing: Limited financial disclosure and liquidity.

Oportunidades de crecimiento

  • Expansion of ATM Network: THC Farmaceuticals can grow by expanding its ATM network within Utah and potentially into neighboring states. Identifying strategic locations with high foot traffic and limited ATM access is crucial. The market for ATM services in underserved areas presents an opportunity to increase transaction volume and revenue, although this requires capital investment and operational expertise.
  • Strategic Partnerships: Forming partnerships with local businesses and event organizers can increase ATM visibility and usage. Offering exclusive deals or discounts to customers who use THC Farmaceuticals' ATMs can incentivize transactions. These partnerships can create a mutually beneficial ecosystem, driving revenue for both the company and its partners.
  • Technological Upgrades: Upgrading existing ATMs with advanced features such as contactless payment options and mobile wallet integration can attract a wider customer base. Investing in secure and reliable ATM technology is essential for maintaining customer trust and preventing fraud. These upgrades can enhance the user experience and increase transaction volume.
  • Targeted Marketing Campaigns: Implementing targeted marketing campaigns to promote the convenience and accessibility of THC Farmaceuticals' ATMs can drive customer awareness and usage. Utilizing social media, local advertising, and in-store promotions can effectively reach the target audience. These campaigns should highlight the benefits of using ATMs for cash transactions.
  • Diversification of Services: Exploring opportunities to offer additional services through its ATM network, such as bill payment and prepaid card loading, can generate new revenue streams. Partnering with service providers to offer these value-added services can enhance the attractiveness of THC Farmaceuticals' ATMs. This diversification can increase customer engagement and loyalty.

Oportunidades

  • Expansion into new locations.
  • Strategic partnerships.
  • Technological upgrades.
  • Diversification of services.

Amenazas

  • Competition from larger ATM networks.
  • Increasing use of digital payment solutions.
  • Regulatory changes.
  • Economic downturn.

Ventajas competitivas

  • Limited geographic focus in Utah.
  • Established relationships with local businesses.
  • Convenient ATM locations in high-traffic areas.

Acerca de CBDG

Founded in 2008 and based in Scottsdale, Arizona, THC Farmaceuticals, Inc., formerly known as City Media, Inc., transitioned to its current name in February 2015. The company operates as a subsidiary of Weed Growth Fund, Inc. Its primary business involves owning and operating non-financial institution cash-dispensing automated teller machines (ATMs) at third-party owned retail and commercial locations. These ATMs are strategically placed in locations such as hotels, stores, and bowling alleys, targeting small and medium-sized businesses with high customer traffic. As of June 30, 2015, THC Farmaceuticals had a total of eight ATMs in operation along the Wasatch Front in the State of Utah. The company's operations are limited geographically and in scale, focusing on providing convenient cash access in specific locales.

Qué hacen

  • Owns and operates cash-dispensing ATMs.
  • Places ATMs in third-party retail and commercial locations.
  • Targets hotels, stores, and bowling alleys.
  • Focuses on small and medium-sized businesses.
  • Provides cash access in high-traffic areas.
  • Operates in the State of Utah.

Modelo de Negocio

  • Generates revenue from transaction fees charged to ATM users.
  • Partners with retail and commercial locations to host ATMs.
  • Maintains and services its ATM network.

Contexto de la Industria

THC Farmaceuticals, Inc. operates within the broader financial services industry, specifically in the niche market of non-bank ATM operations. The ATM market is characterized by established players and increasing competition from digital payment solutions. While the overall ATM market is mature, opportunities exist for smaller operators to serve niche markets and specific geographic areas. THC Farmaceuticals' limited scale and focus on the Utah market position it as a micro-player within this landscape, facing competition from larger ATM networks and evolving payment technologies.

Clientes Clave

  • Retail customers needing cash access.
  • Small and medium-sized businesses hosting ATMs.
  • Tourists and visitors requiring cash transactions.
Confianza de la IA: 69% Actualizado: 15 mar 2026

Finanzas

Gráfico e información

Precio de la acción de THC Farmaceuticals, Inc. (CBDG): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para CBDG.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CBDG.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para CBDG.

MoonshotScore

42/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de CBDG en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Ed Rosenthal

CEO

Information on Ed Rosenthal's background is not available in the provided data. Further research would be needed to determine his career history, education, and previous roles. Without this information, a comprehensive profile cannot be created.

Historial: Information on Ed Rosenthal's track record is not available in the provided data. Further research would be needed to determine his key achievements, strategic decisions, and company milestones under his leadership. Without this information, a comprehensive assessment cannot be provided.

Información del mercado OTC de CBDG

The OTC Other tier represents the lowest tier of the OTC market, indicating that THC Farmaceuticals, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial information available and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited liquidity and transparency.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for THC Farmaceuticals, Inc. (CBDG) is likely very limited given its OTC Other listing. This typically translates to low trading volume, potentially wide bid-ask spreads, and difficulty in executing large trades without significantly impacting the price. Investors should be prepared for potential challenges in buying or selling shares quickly and at desired prices.
Factores de riesgo OTC:
  • Limited financial disclosure.
  • Low trading volume and liquidity.
  • Potential for price manipulation.
  • Higher risk of fraud or scams.
  • Limited regulatory oversight.
Lista de verificación de diligencia debida:
  • Verify the company's registration and legal status.
  • Review available financial statements and disclosures.
  • Assess the company's business model and revenue streams.
  • Research the company's management team and their track record.
  • Evaluate the company's competitive landscape and market position.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor.
Señales de legitimidad:
  • Subsidiary of Weed Growth Fund, Inc.
  • Operational ATM network in Utah.
  • Established business since 2008.

Preguntas Comunes Sobre CBDG

¿Cuáles son los factores clave para evaluar CBDG?

THC Farmaceuticals, Inc. (CBDG) actualmente tiene una puntuación IA de 42/100, indicando puntuación baja. Fortaleza clave: Established ATM network in Utah.. Riesgo principal a monitorear: Potential: Increased competition from larger ATM networks.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de CBDG?

CBDG actualmente puntúa 42/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de CBDG?

Los precios de CBDG se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre CBDG?

La cobertura de analistas para CBDG incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en CBDG?

Las categorías de riesgo para CBDG incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Increased competition from larger ATM networks.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de CBDG?

La relación P/E para CBDG compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está CBDG sobrevalorada o infravalorada?

Determinar si THC Farmaceuticals, Inc. (CBDG) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de CBDG?

THC Farmaceuticals, Inc. (CBDG) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited information available on THC Farmaceuticals, Inc.
  • OTC market carries higher risks.
  • Financial data is limited.
Fuentes de datos

Popular Stocks